title: Hydralazine-induced lupus erythematosis.
authors.affiliation: From the Kaiser Permanente, Anaheim, CA.
authors.forename: Joel
authors.initials: J
authors.lastname: Handler
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects*; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D012460:Sulfasalazine / Q000008:administration & dosage
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D006830:Hydralazine; D012460:Sulfasalazine